Dr Reddy’s and Prestige BioPharma collaborate to commercialise trastuzumab biosimilar
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
It is estimated that one-third of our country’s population has some form of these disorders
Nelarabine is in a class of medications called antimetabolites
Two out of three people under the age of 40 are at risk of prediabetes
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Subscribe To Our Newsletter & Stay Updated